CUAMC
TCRR

China Universal Asset Management Company’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

China Universal Asset Management Company’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-361
Closed -$1K – 498
2022
Q3 		$1K Buy
+361
New +$1.05K ﹤0.01% 434

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

China Universal Asset Management Company's TCRR Position: Q4 2022 in Review

China Universal Asset Management Company sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q4 2022, closing a stake of 361 shares — an estimated $1K sold.

China Universal Asset Management Company first reported a position in TCRR in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 63 funds tracked by Wall St. Rank hold TCRR as of Q4 2022.

  • China Universal Asset Management Company reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 361 TCR2 Therapeutics Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • China Universal Asset Management Company first reported a position in TCR2 Therapeutics Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's TCR2 Therapeutics Inc. Common Stock position peaked at $1K in Q3 2022.
  • 63 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.